AFTD/ALS Association Award to BioSensics | PAMSys ULM Publication

We are thrilled to announce a $400k award to BioSensics from the Association for Frontotemporal Degeneration (AFTD) and the ALS Association.

The "AFTD-ALS Association Digital Assessment Tools for FTD and ALS Award" aims to expand the BioDigit ALS and BioDigit PSP studies to two additional FTD disorders. We will collect longitudinal clinical, sensor and speech data using PAMSys^TM and BioDigit Speech^TM, and develop monitoring digital biomarkers for tracking FTD by working with the FDA Biomarker Qualification program. 

The project is in partnership with Chiadi Onyike, MD at the Johns Hopkins Medical Center, and in collaboration with James Berry, MD (Massachusetts General Hospital), and Xiaowei Su, MD, PhD and Zachary Simmons, MD (Penn State College of Medicine). 

Also I would like to share with you our recent paper related to PAMSys ULM^TM, published in Frontiers in Neurology. The paper, titled "A deep learning wearable-based solution for continuous at-home monitoring of upper limb goal-directed movements" showcases the use of PAMSys ULM^TM in healthy adults and stroke patients. 

PAMSys ULM™ is currently being used in studies in ALS, Friedrich’s ataxia, myasthenia gravis, stroke, Huntington's disease, and inclusion body myositis for continuous monitoring of upper limb function during activities of daily living.